Thirty human immunodeficiency virus-positive patients carrying Candida albicans in their oropharynx were treated with fluconazole and were monitored for 90 to 570 days. Fluconazole-resistant C. albicans (MIC, >32 ,ig/ml) appeared only in seven patients and only after 90 days of treatment corresponding to a total dose of more than 10 g. Resistance was not associated with resistance to other azole derivatives. Susceptible and resistant strains from each patient had the same genotype (as defined by electrophoretic karyotype and restriction fragment length polymorphism). Thus, the resistant strains were selected by the antimycotic treatment from the susceptible strain present in each case.
Oropharyngeal candidiasis is the most frequent opportunistic infection in patients with AIDS (27) . Fluconazole is the best azole drug for the treatment of candidiasis, because its MIC is low, its pharmacokinetic properties are good, and it is well tolerated (6) . Of human immunodeficiency virus (HIV) patients with symptoms of candidiasis, 80 to 100% recover within 5 to 10 days of the initiation of fluconazole therapy (2, 4, 6, 10) . However, 20 to 100% of such patients relapse within a month once treatment is stopped (2, 3, 6, 10) and the fluconazole resistance of Candida albicans strains isolated increases (MICs increase from 6.3 to 100 ,ug/ml) (7, 8, 11, 20, 28) . There is no satisfactory explanation for this phenomenon, and the absence of comparative susceptibility data for isolates recovered before and during treatment does not help identify the origin of the fluconazole insensitivity (16) . It is not known whether strains isolated during relapses are mutants of previously present, susceptible strains, or are newly introduced resistant strains. Genotypic characterization is one of the best methods for comparing strains of C. albicans (13-15, 17, 24) . The genotypic comparison of fluconazole-susceptible and fluconazole-resistant C. albicans strains has been reported for only one case (a non-HIV patient after the failure of a 12-day treatment), and only one genotyping method was used (electrophoretic karyotyping by pulsed-field gel electrophoresis) (1) .
We report the appearance of fluconazole-resistant strains of C. albicans in "Group I, patients colonized by C. albicans. Groups II, III, and IV, patients infected with C. albicans for which the MIC did not change, for which the MIC increased to 16 pg/ml, and for which the MIC increased to 32 ,ug/ml and more, respectively. ' D,,, day when the first specimen was taken; Dx, day when the last specimen was taken.
endpoint is similar to that used by Dupouy-Camey and coworkers (7). All tests for MICs above 16 jig/ml were done in triplicate. The susceptibilities to seven other antifungal agents were determined by using the Mycototal test (Hoechst-Behring) (5) .
Yeast chromosomes were separated by contour-clamped homogeneous electric field electrophoresis in 0.9% agarose gels in a CHEF-DRII system (Bio-Rad, Richmond, Calif.) as previously described (15) . For RFLP analysis, yeast DNA was isolated from 5 ml of overnight culture in Sabouraud liquid medium. Cells were harvested in I M sorbitol and protoplasted in 1 ml of SCEM buffer ( 7 .5], 0.5% sodium dodecyl sulfate, 50 ng of proteinase K per ml) and incubated at 65°C for 30 min. Genomic DNA was precipitated by addition of an equal volume of isopropanol and centrifugation; the pellet was resuspended in 300 jIl of Tris-EDTA buffer and treated with 30 jig of RNase for 30 min at 37°C. This mixture was subjected to extraction once with phenol, and the DNA was precipitated by the addition of an equal volume of isopropanol. The resulting DNA was resuspended in a small volume of Tris-EDTA and stored at 20°C until digestion with Hinfl restriction enzyme (12) as follows. Yeast DNA (10 jig) was incubated with 20 U of Hinfl in a volume of 100 jil for 24 h at 37°C; a further 10 U of enzyme was then added, and the sample was incubated for 24 h at 37°C. The restriction fragments were separated by electrophoresis in 0.7% agarose gels at 80 V cm-for 3 h.
Clinical and biological data from 30 patients with buccal lesions were collected for between 90 and 570 days (mean, 231 days) ( and 480 days for different patients. The highest MICs for strains from two of the group IV patients were 32 jig/ml, and those for strains from the five other patients in this group were 64 jig/ml or higher. The MICs of the five azole derivatives for the seven fluconazole-resistant strains were each less than 8 jig/ml. The CD4 lymphocyte counts were higher than 200/mm3 for eight of the nine group I patients, between 50 and 200 for all the group II patients, and less than 50 for six of the seven group IV patients.
Total doses (TD) of fluconazole were defined as the total fluconazole administered during the study period (Do to DX) ( Table 1 ). The appearance of fluconazole resistance seems to correlate with the TD of fluconazole. As the TD is dependent on the duration of treatment, we compared the MICs for isolates with the administered doses and the frequency and duration of administration for each of the seven group IV patients. Two patients (numbers 28 and 29) carried C. albicans with MICs of fluconazole of 4 jig/ml at the start of treatment; the MIC increased to 32 jig/ml after 240 days of 100 mg of fluconazole per day (patient 28) and after 90 days of 400 mg of fluconazole per day (patient 29). Thus, for these cases it seems that fluconazole resistance correlates with the total quantity of fluconazole administered. A naturally resistant Candida sp. (Candida krusei) was isolated from 5 patients after 120 to 270 days of treatment (TD, more than 5 g), and Torulopsis glabrata was isolated from one patient after 180 days.
The strains isolated from the seven group IV patients (numbers 22 to 29) were genotypically characterized (the average number of strains per patient was six, collected over periods of between 105 and 360 days). Each of the seven patients was colonized by a different strain of C. albicans as defined by EK and RFLP (Fig. 1) . In contrast, the EK and RFLP of all strains isolated from each patient showed identical banding patterns; the increase of fluconazole MIC was thus not reflected by any variation in EK or RFLP (Fig. 1) .
To conclude, clinical and biological investigations confirmed the diagnosis of oropharyngeal candidiasis in 21 of the 30 HIV-infected patients. Fluconazole-resistant C. albicans strains were isolated from 7 of these 21 patients.
Fluconazole MIC values depend on several factors, including culture medium composition and pH and inoculum concentration, in addition to the level of resistance of the isolate (9) . However, these factors were standardized in the microplaque technique used (5, 7) . The increase in the MIC for isolates correlated with the TD of fluconazole: the MIC of fluconazole for the isolates increased to 16 jig/ml for 85% (11 of 13) of the C. albicans infections following a TD greater than 5 g; it increased to 64 jig/ml in three patients (numbers 25, 26, and 30) and more than 64 jig/ml in two patients (numbers 27 and 28) following TD of more than 10 g. In contrast, the MICs were below 4 jig/ml for isolates from patients who received a TD of less than 5 g. Fluconazole resistance appeared in the most immunodeficient patients (fewer than 50 CD4 lymphocytes per mm3); this may have been the case because fungal infections are more frequent and more severe and thus treatment is longer in such patients. It [21] ), but the identity between the susceptible and resistant isolates was satisfactorily demonstrated by the two techniques used.
Fluconazole therapy therefore selected resistant mutants for which the MICs increased with the TD. This resistance characteristic is genetically stable after several cultures. However, the fluconazole-resistant C. albicans isolates remained susceptible to other azole derivatives. It seems therefore that the resistance mechanism does not involve alterations to 14a-demethylase, a cytochrome P-450 enzyme which is a target of all azole compounds (22) . Resistance could be due to alterations of the C5 dehydrogenase involved in ergosterol biosyn-VOL. 32, 1994 on October 28, 2017 by guest http://jcm.asm.org/ Downloaded from thesis (26) , to overproduction of the target cytochrome P-450 (as in T. glabrata, [23] ), or to selective reduced permeability (18) . The successive increases in the MIC of fluconazole suggest that there were several events, possibly repeated amplification of a gene encoding a target, or independent events associated with different targets. Further studies concerning fluconazole resistance are in progress.
